Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Pharm Res. 2022 Aug 2;39(11):2781–2799. doi: 10.1007/s11095-022-03344-5

Table 4.

Emitted dose, fine particle fraction, emitted fine particle fraction of spray dried formulations (mean ± standard deviation, n=3)

Formulation Drug Emitted Dose (%) Fine Particle Fraction (%) Emitted Fine Particle Fraction (%)

Colistin alone Colistin 88.9 ± 1.7 79.9 ± 2.4 89.9 ± 1.0
1:1 Col a -Tob b Colistin 90.8 ± 1.1 85.2 ± 0.9 * 93.9 ± 3.2 *
Tobramycin 89.5 ± 0.5 # 83.29 ± 1.3 # 93.1 ± 0.7 #
1:5 Col-Tob Colistin 90.6 ± 0.5 84.8 ± 2.8 93.6 ± 2.7 *
Tobramycin 89.6 ± 0.8 # 82.7 ± 0.7 # 92.3 ± 1.0 #
Tobramycin alone Tobramycin 56.0 ± 3.3 44.7 ± 2.4 79.9 ± 1.6
*

indicates significant difference compared to the spray dried colistin alone, p < 0.05.

#

indicates significant difference compared to the spray dried tobramycin alone, p < 0.05.

a

Col – colistin

b

Tob – tobramycin